Need to know

Popular Thyroid Medication Failed Inspection AFTER It’s Public Distribution- High Recall Alert Happening

By

On August 9th, 2018, a worldwide recall was alerted for a popular medication to treat hypothyroidism.

Wholesalers have been advised to stop distribution of the medication labeled “Levothyroxine and Liothyronine (Thyroid Tablets, USP).”

According to the U.S. Food and Drug Administration, Westminster Pharmaceuticals, LLC is recalling all lots of the medication.

The FDA site goes on to say the medication is being recalled “as a precaution because they were manufactured using active pharmaceutical ingredients that were sourced prior to the FDA’s Import Alert of Sichuan Friendly Pharmaceutical Co., Ltd., which as a result of a 2017 inspection were found to have deficiencies with Current Good Manufacturing Practices (cGMP).”

Thyroid tablets such as Levothyroxine and Liothyronine are used for “oral use is a natural preparation derived from porcine thyroid glands.”

Because this is is a more precautionary recall, patients taking these medications are being advised to consult their doctor. The FDA shares that patients depending on this medication should continue taking it as it is used to treat serious medical conditions.

100-count bottles are being recalled. To see if your medication is affected, you can check the products NDC’s, Product Description, Lot numbers and Expiration dates are listed below. Click here for a full list of the lots that are being recalled.

If you have questions, comments, or concerns, please reach out to Westminster’s Regulatory Affairs department by phone at: 888-354-9939. Live calls are received Monday-Friday, 9:00AM – 5:00PM EST with voicemail available 24 hours/day, 7 days/week or email recalls@wprx.com.

Comments are closed.